1.
Full Text
Structural basis for substrate gripping and translocation by the ClpB AAA+ disaggregase
Nature Communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 2393 - 12
Bacterial ClpB and yeast Hsp104 are homologous Hsp100 protein disaggregases that serve critical functions in proteostasis by solubilizing protein aggregates....
Binding | Translocation | Yeast | Polypeptides | ClpB protein | Homology | Trimers | Substrates | Proteins | Domains | Casein | HSP100 protein | Adenosine triphosphate
Binding | Translocation | Yeast | Polypeptides | ClpB protein | Homology | Trimers | Substrates | Proteins | Domains | Casein | HSP100 protein | Adenosine triphosphate
Journal Article
Biophysical Journal, ISSN 0006-3495, 05/2019, Volume 116, Issue 10, pp. 1856 - 1872
Heat shock protein (Hsp) 104 is a hexameric ATPases associated with diverse cellular activities motor protein that enables cells to survive extreme stress....
CLPA CHAPERONE | ATP-DEPENDENT TRANSLOCATION | BIOPHYSICS | DNA | ESCHERICHIA-COLI | STEP-SIZE | CENTRAL PORE | COMMON MECHANISM | SINGLE TURNOVER KINETICS | STOPPED-FLOW | PROTEIN DISAGGREGATION | Proteins | Hydrolysis | Medical colleges | Nervous system diseases | Analysis | Heat shock proteins | Adenosine triphosphatase | Protein binding
CLPA CHAPERONE | ATP-DEPENDENT TRANSLOCATION | BIOPHYSICS | DNA | ESCHERICHIA-COLI | STEP-SIZE | CENTRAL PORE | COMMON MECHANISM | SINGLE TURNOVER KINETICS | STOPPED-FLOW | PROTEIN DISAGGREGATION | Proteins | Hydrolysis | Medical colleges | Nervous system diseases | Analysis | Heat shock proteins | Adenosine triphosphatase | Protein binding
Journal Article
Biophysical Journal, ISSN 0006-3495, 01/2013, Volume 104, Issue 2, pp. 570a - 570a
Journal Article
Cell, ISSN 0092-8674, 01/2014, Volume 156, Issue 1-2, pp. 170 - 182
There are no therapies that reverse the proteotoxic misfolding events that underpin fatal neurodegenerative diseases, including amyotrophic lateral sclerosis...
PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEURONS | DISORDERS | TOXICITY | AMYOTROPHIC-LATERAL-SCLEROSIS | MODEL | MUTATIONS | CHAPERONE | AGGREGATION | DISAGGREGATION | CELL BIOLOGY | Parkinson Disease - therapy | Proteostasis Deficiencies - metabolism | Neurons - pathology | Proteostasis Deficiencies - therapy | Humans | Neurons - cytology | DNA-Binding Proteins - metabolism | Heat-Shock Proteins - genetics | Parkinson Disease - metabolism | Disease Models, Animal | Protein Structure, Tertiary | Parkinson Disease - pathology | Animals, Genetically Modified | Heat-Shock Proteins - metabolism | Proteostasis Deficiencies - pathology | Models, Molecular | RNA-Binding Protein FUS - metabolism | Saccharomyces cerevisiae Proteins - genetics | Protein Folding | Caenorhabditis elegans | Animals | Mutagenesis | Saccharomyces cerevisiae Proteins - metabolism | alpha-Synuclein - metabolism | Heat-Shock Proteins - chemistry | Saccharomyces cerevisiae Proteins - chemistry | Proteins | Heat shock proteins | Amyotrophic lateral sclerosis | Nervous system diseases | Analysis | Adenosine triphosphatase
PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEURONS | DISORDERS | TOXICITY | AMYOTROPHIC-LATERAL-SCLEROSIS | MODEL | MUTATIONS | CHAPERONE | AGGREGATION | DISAGGREGATION | CELL BIOLOGY | Parkinson Disease - therapy | Proteostasis Deficiencies - metabolism | Neurons - pathology | Proteostasis Deficiencies - therapy | Humans | Neurons - cytology | DNA-Binding Proteins - metabolism | Heat-Shock Proteins - genetics | Parkinson Disease - metabolism | Disease Models, Animal | Protein Structure, Tertiary | Parkinson Disease - pathology | Animals, Genetically Modified | Heat-Shock Proteins - metabolism | Proteostasis Deficiencies - pathology | Models, Molecular | RNA-Binding Protein FUS - metabolism | Saccharomyces cerevisiae Proteins - genetics | Protein Folding | Caenorhabditis elegans | Animals | Mutagenesis | Saccharomyces cerevisiae Proteins - metabolism | alpha-Synuclein - metabolism | Heat-Shock Proteins - chemistry | Saccharomyces cerevisiae Proteins - chemistry | Proteins | Heat shock proteins | Amyotrophic lateral sclerosis | Nervous system diseases | Analysis | Adenosine triphosphatase
Journal Article
Minerva Ginecologica, ISSN 0026-4784, 02/2018, Volume 70, Issue 1, pp. 53 - 57
Journal Article
Minerva ginecologica, 02/2018, Volume 70, Issue 1, p. 53
The advent of flexible CO2 laser fiber to gynecology arena might represent a turning point in the use of laser energy on a large-scale basis in gynecological...
Journal Article
Journal of Endometriosis and Pelvic Pain Disorders, ISSN 2284-0265, 07/2017, Volume 9, Issue 3, pp. 206 - 210
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 2007, Volume 15, Issue 10, pp. 3356 - 3367
A wide series of synthetic flavonoids, with druglikeness properties, were developed and evaluated as antitumoral agents against TK-10, MCF-7, and HT-29 human...
Flavonoids | Antitumoral | QSAR | Comet assay | ANTIOXIDANT ACTIVITY | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | COMPLEXES | CELL LINES | CHEMISTRY, ORGANIC | CANCER | 2-HYDROXYCHALCONES | INHIBITION | comet assay | POTENTIAL HYPOXIC CYTOTOXINS | ANTICANCER | antitumoral | BEARING | flavonoids | N-OXIDE DERIVATIVES | Magnetic Resonance Spectroscopy | Antineoplastic Agents - chemical synthesis | Humans | Structure-Activity Relationship | Chromatography, Thin Layer | Comet Assay | DNA, Neoplasm - drug effects | Flavones - chemical synthesis | Spectrophotometry, Infrared | Chalcones - chemical synthesis | Chromosome Aberrations - drug effects | X-Ray Diffraction | Mass Spectrometry | Chalcones - pharmacology | Cell Line, Tumor | Indicators and Reagents | Antineoplastic Agents - pharmacology | DNA Damage | Flavones - pharmacology | Drug Screening Assays, Antitumor
Flavonoids | Antitumoral | QSAR | Comet assay | ANTIOXIDANT ACTIVITY | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | COMPLEXES | CELL LINES | CHEMISTRY, ORGANIC | CANCER | 2-HYDROXYCHALCONES | INHIBITION | comet assay | POTENTIAL HYPOXIC CYTOTOXINS | ANTICANCER | antitumoral | BEARING | flavonoids | N-OXIDE DERIVATIVES | Magnetic Resonance Spectroscopy | Antineoplastic Agents - chemical synthesis | Humans | Structure-Activity Relationship | Chromatography, Thin Layer | Comet Assay | DNA, Neoplasm - drug effects | Flavones - chemical synthesis | Spectrophotometry, Infrared | Chalcones - chemical synthesis | Chromosome Aberrations - drug effects | X-Ray Diffraction | Mass Spectrometry | Chalcones - pharmacology | Cell Line, Tumor | Indicators and Reagents | Antineoplastic Agents - pharmacology | DNA Damage | Flavones - pharmacology | Drug Screening Assays, Antitumor
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, p. e110115
Hsp104 is a hexameric AAA+ protein that utilizes energy from ATP hydrolysis to dissolve disordered protein aggregates as well as amyloid fibers. Interestingly,...
FIREFLY LUCIFERASE | SACCHAROMYCES-CEREVISIAE HSP104 | AGENT GUANIDINIUM CHLORIDE | PRION PROPAGATION | MULTIDISCIPLINARY SCIENCES | AGGREGATED PROTEINS | PROMISCUOUS INHIBITORS | COMMON MECHANISM | NUCLEOTIDE-BINDING | MIDDLE DOMAIN | PROTEIN DISAGGREGATION | Molecular Chaperones | Saccharomyces cerevisiae Proteins - antagonists & inhibitors | Heat-Shock Proteins - metabolism | Adenosine Triphosphatases - metabolism | Heat-Shock Proteins - antagonists & inhibitors | Protein Aggregation, Pathological - drug therapy | Suramin - chemistry | Saccharomyces cerevisiae - metabolism | Adenosine Triphosphatases - antagonists & inhibitors | Small Molecule Libraries - chemistry | Animals | Protein Binding - drug effects | Saccharomyces cerevisiae Proteins - metabolism | Small Molecule Libraries - isolation & purification | Protein Aggregation, Pathological - metabolism | Suramin - pharmacology | Heat-Shock Proteins - chemistry | Protein Aggregates - drug effects | Protein Structure, Tertiary - drug effects | Saccharomyces cerevisiae Proteins - chemistry | Hydrolysis | Heat shock proteins | Adenosine triphosphatase | Suramin | ClpB protein | Disease | Homology | Biochemistry | Translocase | Parasites | Kinases | Fibers | Proteins | E coli | Cell cycle | Amyloid | Inhibition | African trypanosomiasis | Adenosine triphosphate | Vector-borne diseases | Hexamers | Glycerol | Hsp70 protein | Biophysics | Hsp40 protein | Medical screening | Side effects | Inhibitors | Collaboration | Mutation | Binding sites | Heat shock | Structure-function relationships
FIREFLY LUCIFERASE | SACCHAROMYCES-CEREVISIAE HSP104 | AGENT GUANIDINIUM CHLORIDE | PRION PROPAGATION | MULTIDISCIPLINARY SCIENCES | AGGREGATED PROTEINS | PROMISCUOUS INHIBITORS | COMMON MECHANISM | NUCLEOTIDE-BINDING | MIDDLE DOMAIN | PROTEIN DISAGGREGATION | Molecular Chaperones | Saccharomyces cerevisiae Proteins - antagonists & inhibitors | Heat-Shock Proteins - metabolism | Adenosine Triphosphatases - metabolism | Heat-Shock Proteins - antagonists & inhibitors | Protein Aggregation, Pathological - drug therapy | Suramin - chemistry | Saccharomyces cerevisiae - metabolism | Adenosine Triphosphatases - antagonists & inhibitors | Small Molecule Libraries - chemistry | Animals | Protein Binding - drug effects | Saccharomyces cerevisiae Proteins - metabolism | Small Molecule Libraries - isolation & purification | Protein Aggregation, Pathological - metabolism | Suramin - pharmacology | Heat-Shock Proteins - chemistry | Protein Aggregates - drug effects | Protein Structure, Tertiary - drug effects | Saccharomyces cerevisiae Proteins - chemistry | Hydrolysis | Heat shock proteins | Adenosine triphosphatase | Suramin | ClpB protein | Disease | Homology | Biochemistry | Translocase | Parasites | Kinases | Fibers | Proteins | E coli | Cell cycle | Amyloid | Inhibition | African trypanosomiasis | Adenosine triphosphate | Vector-borne diseases | Hexamers | Glycerol | Hsp70 protein | Biophysics | Hsp40 protein | Medical screening | Side effects | Inhibitors | Collaboration | Mutation | Binding sites | Heat shock | Structure-function relationships
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 08/2010, Volume 334, Issue 2, pp. 665 - 672
Clinical and preclinical studies suggest that nicotinic acetylcholine receptors are involved in affective disorders; therefore, the potential therapeutic value...
INDUCED HYPOPHAGIA TEST | SMOKING-CESSATION | DEPRESSION | ACETYLCHOLINE-RECEPTORS | ANTIDEPRESSANTS | RAT | PHARMACOLOGY & PHARMACY | FORCED SWIM TEST | MICE | FLUOXETINE | ALPHA-4-BETA-2 | Mood Disorders - drug therapy | Drug Partial Agonism | Mood Disorders - psychology | Varenicline | Anxiety - psychology | Male | Anxiety - drug therapy | Azetidines - pharmacology | Benzazepines - pharmacology | Nicotinic Agonists - therapeutic use | Nicotine - pharmacology | Quinoxalines - pharmacology | Depression - drug therapy | Animals | Azetidines - therapeutic use | Benzazepines - therapeutic use | Depression - psychology | Behavior, Animal - drug effects | Mice | Pyridines - pharmacology | Nicotinic Agonists - pharmacology | Chimera | Pyridines - therapeutic use | Quinoxalines - therapeutic use
INDUCED HYPOPHAGIA TEST | SMOKING-CESSATION | DEPRESSION | ACETYLCHOLINE-RECEPTORS | ANTIDEPRESSANTS | RAT | PHARMACOLOGY & PHARMACY | FORCED SWIM TEST | MICE | FLUOXETINE | ALPHA-4-BETA-2 | Mood Disorders - drug therapy | Drug Partial Agonism | Mood Disorders - psychology | Varenicline | Anxiety - psychology | Male | Anxiety - drug therapy | Azetidines - pharmacology | Benzazepines - pharmacology | Nicotinic Agonists - therapeutic use | Nicotine - pharmacology | Quinoxalines - pharmacology | Depression - drug therapy | Animals | Azetidines - therapeutic use | Benzazepines - therapeutic use | Depression - psychology | Behavior, Animal - drug effects | Mice | Pyridines - pharmacology | Nicotinic Agonists - pharmacology | Chimera | Pyridines - therapeutic use | Quinoxalines - therapeutic use
Journal Article
Journal of Nursing Scholarship, ISSN 1527-6546, 07/2019, Volume 51, Issue 4, pp. 449 - 458
Purpose To assess changes in the self‐reported performance of smoking cessation interventions according to the 5A's model (Ask; Advise; Assess; Assist; and...
brief intervention | tobacco cessation | smoking cessation | Barriers | healthcare workers | online training | health organizations | nurses | METAANALYSIS | DETERMINANTS | NURSING | KNOWLEDGE | PRACTICE NURSES INTENTION | EDUCATION | PREVALENCE | CARE PROVIDERS | ATTITUDES | SMOKERS | BEHAVIORS | Training | Smoking cessation programs | Services | Usage | Hospitals | Nurses | Practice | Intervention | Health care | Incorporation | Nurse practitioners | Competence | Physicians | Self | Implementation | Smoking cessation | Motivation | Education | Questionnaires | Online instruction | Preparedness | Clinical training | Assistance | Medical personnel | Behavioural aspects | Cessation | Change agents | Clinical practice | Tobacco | Nursing | Facilitators | Clinical medicine | Organizational factors | Smoking
brief intervention | tobacco cessation | smoking cessation | Barriers | healthcare workers | online training | health organizations | nurses | METAANALYSIS | DETERMINANTS | NURSING | KNOWLEDGE | PRACTICE NURSES INTENTION | EDUCATION | PREVALENCE | CARE PROVIDERS | ATTITUDES | SMOKERS | BEHAVIORS | Training | Smoking cessation programs | Services | Usage | Hospitals | Nurses | Practice | Intervention | Health care | Incorporation | Nurse practitioners | Competence | Physicians | Self | Implementation | Smoking cessation | Motivation | Education | Questionnaires | Online instruction | Preparedness | Clinical training | Assistance | Medical personnel | Behavioural aspects | Cessation | Change agents | Clinical practice | Tobacco | Nursing | Facilitators | Clinical medicine | Organizational factors | Smoking
Journal Article
Structure, ISSN 0969-2126, 03/2019, Volume 27, Issue 3, pp. 449 - 463.e7
Hsp104 is an AAA+ protein disaggregase with powerful amyloid-remodeling activity. All nonmetazoan eukaryotes express Hsp104 while eubacteria express an Hsp104...
DOMAIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | COMPONENTS | MODEL | MICROSCOPY | CELL BIOLOGY | REFINEMENT | BIOPHYSICS | MAPS | MUTATIONS | PROTEINS | BINDING | PLASTICITY | Heat shock proteins | Medical colleges | Nervous system diseases | Structure | Molecular biology | Crystals | BASIC BIOLOGICAL SCIENCES
DOMAIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | COMPONENTS | MODEL | MICROSCOPY | CELL BIOLOGY | REFINEMENT | BIOPHYSICS | MAPS | MUTATIONS | PROTEINS | BINDING | PLASTICITY | Heat shock proteins | Medical colleges | Nervous system diseases | Structure | Molecular biology | Crystals | BASIC BIOLOGICAL SCIENCES
Journal Article
Nicotine and Tobacco Research, ISSN 1462-2203, 2011, Volume 13, Issue 1, pp. 41 - 46
Introduction: Clinical and preclinical studies suggest that regulation of nicotinic acetylcholine receptors (nAChR) maybe involved in the etiology of...
CHOLINERGIC-RECEPTOR | SMOKING-CESSATION | PARTIAL AGONISTS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | SAZETIDINE-A | MARBLE-BURYING BEHAVIOR | SMOKERS | ABSTINENCE | IN-VIVO | SENSITIVITY | SUBSTANCE ABUSE | BRAIN | Receptors, Nicotinic - metabolism | Thalamus - metabolism | Varenicline | Male | Benzazepines - pharmacology | Hippocampus - drug effects | Thalamus - drug effects | Cerebral Cortex - metabolism | Nicotine - pharmacology | Quinoxalines - pharmacology | Up-Regulation - drug effects | Hippocampus - metabolism | Animals | Substance Withdrawal Syndrome - metabolism | Mice | Cerebral Cortex - drug effects | Smoking Cessation | Brief Reports
CHOLINERGIC-RECEPTOR | SMOKING-CESSATION | PARTIAL AGONISTS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | SAZETIDINE-A | MARBLE-BURYING BEHAVIOR | SMOKERS | ABSTINENCE | IN-VIVO | SENSITIVITY | SUBSTANCE ABUSE | BRAIN | Receptors, Nicotinic - metabolism | Thalamus - metabolism | Varenicline | Male | Benzazepines - pharmacology | Hippocampus - drug effects | Thalamus - drug effects | Cerebral Cortex - metabolism | Nicotine - pharmacology | Quinoxalines - pharmacology | Up-Regulation - drug effects | Hippocampus - metabolism | Animals | Substance Withdrawal Syndrome - metabolism | Mice | Cerebral Cortex - drug effects | Smoking Cessation | Brief Reports
Journal Article
eLife, ISSN 2050-084X, 08/2015, Volume 4, Issue 2015
Semen is the main vector for HIV transmission and contains amyloid fibrils that enhance viral infection. Available microbicides that target viral components...
FIBRIL FORMATION | REPLICATION | HEPATITIS-C VIRUS | ALZHEIMERS-DISEASE | BIOLOGY | CANDIDATE MICROBICIDES | FORCE-FIELD | HUMAN-IMMUNODEFICIENCY-VIRUS | CELL-LINES | SEXUAL TRANSMISSION | SEMEN-MEDIATED ENHANCEMENT | Anti-HIV Agents - pharmacology | Amyloid - antagonists & inhibitors | HIV Infections - prevention & control | Humans | Semen - chemistry | Semen - drug effects | Male | Disease Transmission, Infectious - prevention & control | Organophosphates - pharmacology | Bridged-Ring Compounds - pharmacology | HIV Infections - transmission | Semen - virology | Antimetabolites - pharmacology
FIBRIL FORMATION | REPLICATION | HEPATITIS-C VIRUS | ALZHEIMERS-DISEASE | BIOLOGY | CANDIDATE MICROBICIDES | FORCE-FIELD | HUMAN-IMMUNODEFICIENCY-VIRUS | CELL-LINES | SEXUAL TRANSMISSION | SEMEN-MEDIATED ENHANCEMENT | Anti-HIV Agents - pharmacology | Amyloid - antagonists & inhibitors | HIV Infections - prevention & control | Humans | Semen - chemistry | Semen - drug effects | Male | Disease Transmission, Infectious - prevention & control | Organophosphates - pharmacology | Bridged-Ring Compounds - pharmacology | HIV Infections - transmission | Semen - virology | Antimetabolites - pharmacology
Journal Article
Chemistry & Biology, ISSN 1074-5521, 08/2015, Volume 22, Issue 8, pp. 1074 - 1086
Naturally occurring proteolytic fragments of prostatic acid phosphatase (PAP248-286 and PAP85-120) and semenogelins (SEM1 and SEM2) form amyloid fibrils in...
NEURODEGENERATIVE DISEASE | FIBRIL FORMATION | PRION PROPAGATION | SEMEN | BIOCHEMISTRY & MOLECULAR BIOLOGY | BINDING DOMAIN | DISORDERS | SEXUAL TRANSMISSION | MIDDLE DOMAIN | PEPTIDE | PROTEIN DISAGGREGATION | Anti-HIV Agents - pharmacology | HIV-1 | Amyloid - antagonists & inhibitors | Cell Line | Saccharomyces cerevisiae Proteins - pharmacology | Humans | Semen - chemistry | Semen - drug effects | Male | Peptide Fragments - pharmacology | Amyloid - chemistry | Saccharomyces cerevisiae Proteins - chemical synthesis | Heat-Shock Proteins - pharmacology | Anti-HIV Agents - chemical synthesis | Peptide Fragments - chemical synthesis | Amyloidogenic Proteins - metabolism | Anti-HIV Agents - chemistry | Peptide Fragments - chemistry | Heat-Shock Proteins - chemical synthesis | Proteolysis | HIV Infections - drug therapy | Heat-Shock Proteins - chemistry | Saccharomyces cerevisiae Proteins - chemistry | Virus diseases | Heat shock proteins | HIV (Viruses) | Proteases | Health aspects | HIV infection | Medical colleges | Phosphatases
NEURODEGENERATIVE DISEASE | FIBRIL FORMATION | PRION PROPAGATION | SEMEN | BIOCHEMISTRY & MOLECULAR BIOLOGY | BINDING DOMAIN | DISORDERS | SEXUAL TRANSMISSION | MIDDLE DOMAIN | PEPTIDE | PROTEIN DISAGGREGATION | Anti-HIV Agents - pharmacology | HIV-1 | Amyloid - antagonists & inhibitors | Cell Line | Saccharomyces cerevisiae Proteins - pharmacology | Humans | Semen - chemistry | Semen - drug effects | Male | Peptide Fragments - pharmacology | Amyloid - chemistry | Saccharomyces cerevisiae Proteins - chemical synthesis | Heat-Shock Proteins - pharmacology | Anti-HIV Agents - chemical synthesis | Peptide Fragments - chemical synthesis | Amyloidogenic Proteins - metabolism | Anti-HIV Agents - chemistry | Peptide Fragments - chemistry | Heat-Shock Proteins - chemical synthesis | Proteolysis | HIV Infections - drug therapy | Heat-Shock Proteins - chemistry | Saccharomyces cerevisiae Proteins - chemistry | Virus diseases | Heat shock proteins | HIV (Viruses) | Proteases | Health aspects | HIV infection | Medical colleges | Phosphatases
Journal Article